6 December 2021 - Deborah Wilkes
- Media reports suggest WBA to explore options for Boots pharmacy chain
- Boots has more than 2,200 stores in the UK
- McKesson recently agreed to sell its UK business including Lloydspharmacy chain
Media reports suggest Walgreens Boots Alliance (WBA) is set to explore a range of options for its Boots pharmacy chain, including divestment.
Quoting “city sources”, Sky News said WBA was lining up Goldman Sachs to advise it on the review but the process might not lead to a sale of the business.
Boots is the largest pharmacy chain in the UK, operating more than 2,200 stores.
At the time this News story went to press, WBA had not responded to a request from OTCToolbox to comment on the Sky News report.
The report comes soon after McKesson Corporation announced it was selling its UK businesses, including the Lloydspharmacy chain, to private-equity firm Aurelius for an enterprise value of GBP477 million (USD650 million).
McKesson said the agreement was “another important step in advancing its commitment to streamline the business and fully exit the European region” (click here to read the News story).
WBA recently shifted strategy with the launch of a new business called Walgreens Health to accelerate its capabilities in primary care, post-acute care and home care. The focus is on North America (click here to read the News story).